{"log_id": 9134034455997260501, "direction": 0, "words_result_num": 37, "words_result": [{"probability": {"variance": 0.000198, "average": 0.990062, "min": 0.970185}, "location": {"width": 92, "top": 210, "height": 23, "left": 270}, "words": " 2) CYP3A4"}, {"probability": {"variance": 8.5e-05, "average": 0.995183, "min": 0.948525}, "location": {"width": 744, "top": 235, "height": 41, "left": 271}, "words": "稳态条件下帕罗西汀和细胞色素CYP3A4的底物特非那定合用的体内相互作用研究表明"}, {"probability": {"variance": 0.000584, "average": 0.994395, "min": 0.845437}, "location": {"width": 783, "top": 275, "height": 42, "left": 232}, "words": "帕罗西汀对特非那定的药代动力学没有影响。类似的体内相互作用研究发现帕罗西汀对阿普"}, {"probability": {"variance": 0.007748, "average": 0.9813, "min": 0.435054}, "location": {"width": 779, "top": 315, "height": 44, "left": 232}, "words": "唑仑的药代动力学没有影响,阿普唑仑对帕罗西汀的药代动力学也没有影响帕罗西汀与特"}, {"probability": {"variance": 2.3e-05, "average": 0.996318, "min": 0.983641}, "location": {"width": 545, "top": 360, "height": 37, "left": 234}, "words": "非那定、阿普唑仑和其他作为CYP3A4底物的药物合用不会有害"}, {"probability": {"variance": 0, "average": 0.949964, "min": 0.949964}, "location": {"width": 42, "top": 353, "height": 37, "left": 781}, "words": "。"}, {"probability": {"variance": 0.026211, "average": 0.830572, "min": 0.668674}, "location": {"width": 64, "top": 338, "height": 37, "left": 820}, "words": "约业"}, {"probability": {"variance": 0, "average": 0.948973, "min": 0.948973}, "location": {"width": 35, "top": 353, "height": 36, "left": 885}, "words": "7"}, {"probability": {"variance": 0.000132, "average": 0.995324, "min": 0.939078}, "location": {"width": 737, "top": 394, "height": 43, "left": 271}, "words": "6.丙环定:每天给药帕罗西汀会显著增加丙环定的血浆浓度。如果发现抗胆碱能效应"}, {"probability": {"variance": 1.2e-05, "average": 0.99705, "min": 0.990209}, "location": {"width": 202, "top": 445, "height": 31, "left": 235}, "words": "丙环定的剂量应当减少"}, {"probability": {"variance": 0.001955, "average": 0.966943, "min": 0.854894}, "location": {"width": 222, "top": 486, "height": 24, "left": 275}, "words": "7.三环抗抑郁药(TCAs)"}, {"probability": {"variance": 0.002068, "average": 0.98232, "min": 0.734124}, "location": {"width": 749, "top": 513, "height": 39, "left": 277}, "words": "因为帕罗西汀能够抑制TCA代谢,故慎用于与三环抗抑郁药(TCAs)合用TCA与本品"}, {"probability": {"variance": 0.000674, "average": 0.986646, "min": 0.902106}, "location": {"width": 417, "top": 557, "height": 35, "left": 238}, "words": "合用时要减少TCA剂量,需要监测血浆TCA浓度"}, {"probability": {"variance": 0.000519, "average": 0.993818, "min": 0.860009}, "location": {"width": 737, "top": 590, "height": 40, "left": 278}, "words": "8.与血浆蛋白高度结合的药物:由于帕罗西汀与血浆蛋白高度结合,服用另一种与蛋"}, {"probability": {"variance": 6.7e-05, "average": 0.997091, "min": 0.949231}, "location": {"width": 776, "top": 628, "height": 42, "left": 238}, "words": "白高度结合药物的患者在使用本品时,其他药物的游离浓度会升高,就有可能导致不良事"}, {"probability": {"variance": 0.000171, "average": 0.995106, "min": 0.940114}, "location": {"width": 635, "top": 670, "height": 39, "left": 239}, "words": "件:相反,其他蛋白高度结合药物置换出来的帕罗西汀也会引起不良反应"}, {"probability": {"variance": 0.004522, "average": 0.978635, "min": 0.605898}, "location": {"width": 736, "top": 707, "height": 39, "left": 280}, "words": "9.影响止血的药物(如 NSAIDS、阿司匹林和华法林):血小板释放的5-羟色胺在止血"}, {"probability": {"variance": 0.000853, "average": 0.992726, "min": 0.8165}, "location": {"width": 777, "top": 745, "height": 42, "left": 241}, "words": "中起重要作用。病例对照和队列分析流行病学研究证明,干扰5-羟色胺再摄取的抗精神病"}, {"probability": {"variance": 0.004327, "average": 0.985389, "min": 0.590923}, "location": {"width": 775, "top": 784, "height": 42, "left": 241}, "words": "药物应用与上消化道出血有关,同时还证明了联合使用 NSATD或阿司匹林会增加出血的风险"}, {"probability": {"variance": 0.002542, "average": 0.979995, "min": 0.758215}, "location": {"width": 776, "top": 824, "height": 40, "left": 242}, "words": " SSRIS或 ASNRIS与华法林合用时,抗凝作用发生变化,其中包括出血增加。接受华法林治疗"}, {"probability": {"variance": 9e-06, "average": 0.998313, "min": 0.985568}, "location": {"width": 538, "top": 865, "height": 39, "left": 243}, "words": "的患者当开始或停止使用帕罗西汀时,均需密切观察患者病情"}, {"probability": {"variance": 4e-05, "average": 0.99819, "min": 0.960663}, "location": {"width": 742, "top": 900, "height": 40, "left": 283}, "words": "临床研究表明,帕罗西汀的吸收和药代动力学不受下列因素影响或者只有不明显的影响"}, {"probability": {"variance": 0.000415, "average": 0.993073, "min": 0.886901}, "location": {"width": 627, "top": 941, "height": 39, "left": 254}, "words": "影响很小不需要改变给药方案):包括食物、制酸剂、地高辛、普萘洛尔"}, {"probability": {"variance": 0.002164, "average": 0.985418, "min": 0.719519}, "location": {"width": 730, "top": 978, "height": 40, "left": 298}, "words": "0.抗惊厥药;卡马西平,苯妥英,丙戊酸钠。合用这些药物对癫痫患者中的药代动力"}, {"probability": {"variance": 4e-05, "average": 0.99738, "min": 0.97439}, "location": {"width": 291, "top": 1026, "height": 34, "left": 246}, "words": "学/药效学特征似乎没有什么影响"}, {"probability": {"variance": 0.005425, "average": 0.985348, "min": 0.532638}, "location": {"width": 717, "top": 1057, "height": 38, "left": 303}, "words": "11.酒精:帕罗西汀不增加酒精引起精神和运动机能损害,但是不推荐本品与酒精合用"}, {"probability": {"variance": 0.000149, "average": 0.992891, "min": 0.965802}, "location": {"width": 105, "top": 1109, "height": 25, "left": 255}, "words": "【药物过量】"}, {"probability": {"variance": 0.00151, "average": 0.983136, "min": 0.839062}, "location": {"width": 750, "top": 1132, "height": 41, "left": 290}, "words": "现有资料表明,本品有较大的安全范围。曾有单次服用本品2000mg或与其它药物合用(包"}, {"probability": {"variance": 4.3e-05, "average": 0.996218, "min": 0.97316}, "location": {"width": 791, "top": 1170, "height": 41, "left": 251}, "words": "括酒精)药物过量的报道。过量服用本品后的经验表明,通常报告的与帕罗西汀药物过量相关"}, {"probability": {"variance": 0.000113, "average": 0.995231, "min": 0.950313}, "location": {"width": 770, "top": 1209, "height": 42, "left": 251}, "words": "的不良事件包括嗜睡、昏迷状态、恶心、颤抖、意识模糊、头晕、呕吐、瞳孔散大、发热"}, {"probability": {"variance": 2.6e-05, "average": 0.996955, "min": 0.977994}, "location": {"width": 792, "top": 1249, "height": 41, "left": 251}, "words": "血压变化、头痛、不自主肌肉收缩、激动、焦虑和心动过速。其他观察到的帕罗西汀药物过"}, {"probability": {"variance": 0.000587, "average": 0.991321, "min": 0.88162}, "location": {"width": 787, "top": 1288, "height": 40, "left": 255}, "words": "量(单独或与药物合用)的明显体征和症状包括惊厥(包括癫痫持续状态)、室性心律失常(包"}, {"probability": {"variance": 0.00026, "average": 0.995147, "min": 0.896556}, "location": {"width": 789, "top": 1326, "height": 42, "left": 254}, "words": "括尖端扭转型室性心动过速)、高血压、攻击性反应、晕厥、低血压、木僵、心动过缓、肌张"}, {"probability": {"variance": 0.000693, "average": 0.99225, "min": 0.842171}, "location": {"width": 789, "top": 1366, "height": 40, "left": 257}, "words": "力失调、横纹肌溶解、肝功能异常症状(包括肝功能衰竭、肝坏死、黄疸、肝炎和肝脂肪变"}, {"probability": {"variance": 0.004659, "average": 0.979422, "min": 0.562552}, "location": {"width": 791, "top": 1404, "height": 42, "left": 255}, "words": "性)、5-羟色胺综合征、躁狂反应、肌阵挛、急性肾衰竭和尿潴留。偶有昏迷或心电图变化的"}, {"probability": {"variance": 9e-05, "average": 0.996161, "min": 0.946216}, "location": {"width": 742, "top": 1444, "height": 39, "left": 256}, "words": "事件报道,但很罕见危及生命,多发生在合用其它精神科药物时(伴有或不伴有酒精)"}, {"probability": {"variance": 1.4e-05, "average": 0.997561, "min": 0.98866}, "location": {"width": 144, "top": 1496, "height": 24, "left": 257}, "words": "药物过量的处理"}], "language": 3}